Encube FDA Thursday, March 11, 2021 0.00 Neutral

FDA Approves CLINDAMYCIN PHOSPHATE — Encube Ethicals, Inc.

# FDA Approves Encube Ethicals' Generic Clindamycin Phosphate Gel Encube Ethicals, Inc. received FDA approval for its generic clindamycin phosphate gel 1% (ANDA212438), a topical antibiotic commonly used to treat acne and bacterial skin infections, potentially expanding treatment accessibility and driving competitive pricing in the topical antibiotic market. The approval adds another generic option to this established therapeutic category, likely intensifying price competition among manufacturers.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day